Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain

Acta Diabetologica

Volumn 47, Issue SUPPL. 1, 2010, Pages

  Costi, María ^a   Dilla, Tatiana ^a   Reviriego, Jesús ^a   Castell, Conxa ^b   Goday, Albert ^c  

^a ELI LILLY AND COMPANY   (Spain)

^b Division of Public Health   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Epidemiology; Spain; Treatment; Type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEGLITINIDE; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL;

AGE; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT CARE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SEX RATIO; SPAIN; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPAIN;

EID: 78751627390     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0158-8     Document Type: Article

References (25)

1. PZ Zimmet 1999 Diabetes epidemiology as a tool to trigger diabetes research and care Diabetologia 42 499 518 1:STN:280:DyaK1M3mtlygtA%3D%3D 10.1007/s001250051188 10333041 (Pubitemid 29195999)
2. IM Stratton AI Adler HA Neil DR Matthews SE Manley CA Cull, et al. 2000 Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405 412 1:STN:280:DC%2BD3cvisFWnsg%3D%3D 10.1136/bmj.321.7258.405 10938048
3. L Ettaro TJ Songer P Zhang MM Engelgau 2004 Cost-of-illness studies in diabetes mellitus Pharmacoeconomics 22 149 164 10.2165/00019053-200422030-00002 14871163 (Pubitemid 38333648)
4. M Ruiz-Ramos A Escolar-Pujolar E Mayoral-Sánchez F Corral-San Laureano I Fernández-Fernández 2006 La diabetes mellitus en España: mortalidad, prevalencia, incidencia, costes económicos y desigualdades Gac Sanit 20 supl 1 15 24 10.1157/13086022 16539961
5. Servicio Andaluz de Salud (1993) Estudio DRECA: dieta y riesgo de enfermedades cardiovasculares en Andalucía, Sevilla: Consejería de Salud. http://www.juntadeandalucia.es/servicioandaluzdesalud/publicaciones/ Listadodeterminado.asp?idp=114. Accessed 12 May 2009
6. PL De Pablos-Velasco FJ Martínez-Martín F Rodríguez Pérez, et al. 1997 Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population. Comparison of the 1997 ADA and the 1985 WHO criteria. The Guia Study Diabet Med 18 235 241 10.1046/j.1464-5491.2001.00451.x
7. JA Vázquez S Gaztambide E Soto-Pedre 2000 Estudio prospectivo a 10 años sobre la incidencia y factores de riesgo de diabetes mellitus tipo 2 Med Clin (Barc) 115 534 539
8. S Valdés P Botas E Delgado F Alvarez FD Cadórniga 2007 Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study Diabetes Care 30 9 2258 2263 10.2337/dc06-2461 17536076 (Pubitemid 47359028)
9. MJ Sender M Vernet P Larrosa E Tor M Foz 2002 Características sociodemográficas y clínicas de una población de pacientes con diabetes mellitus Aten Primaria 29 8 474 480
10. The International Diabetes Federation (IDF) (2005) Global guidelines for type 2 diabetes, chap 6. Glucose control levels. http://www.idf.org/home/index. cfm?node=1457. Accessed 12 May 2009
11. A Wright ACF Burden RB Paisey CA Cull RR Holman 2002 Sulfonylurea inadequacy. Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK. Prospective diabetes study (UKPDS 57) Diabetes Care 25 330 336 1:CAS:528:DC%2BD38Xhtlyks74%3D 10.2337/diacare.25.2.330 11815505 (Pubitemid 41079631)
12. M Shichiri H Kishikawa Y Ohkubo N Wake 2000 Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients Diabetes Care 23 suppl 2 B21 B29 10860187
13. The Diabetes Control and Complications Trial Research Group 1993 The effect on intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977 986 10.1056/NEJM199309303291401 (Pubitemid 23307905)
14. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 9131 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
15. N Rae K Secnik T Dilla N Lara X Badía 2008 Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain Patient Prefer Adherence 2 87 95
16. Cardiovascular Risk Protection (2005) The International Diabetes Federation (IDF). Global Guidelines for type 2 diabetes, chap 12. http://www.idf.org/home/index.cfm?node=1457. Accessed 12 May 2009
17. The IDF Worldwide Definition of the Metabolic Syndrome (2006) The International Diabetes Federation (IDF). http://www.idf.org/home/index.cfm?node= 1429. Accessed 12 May 2009
18. Jones S, Benroubi M, Castell C, Goday A, Liebl A, Timlin L, Nicolay C, Simpson A, Tynan A (2009) Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study. Curr Med Res Opin. 30 Jan 2009. [Epub ahead of print]
19. P Gaede H Lund-Andersen HH Parving O Pedersen 2008 Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 6 580 591 1:CAS:528:DC%2BD1cXhs1entLc%3D 10.1056/NEJMoa0706245 18256393 (Pubitemid 351214285)
20. AI Adler IM Stratton HA Neil JS Yudkin DR Matthews CA Cull AD Wright RC Turner RR Holman 2000 Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study BMJ 321 7258 412 419 1:STN:280:DC%2BD3cvisFWnsw%3D%3D 10.1136/bmj.321.7258.412 10938049
21. SH Saydah J Fradkin CC Cowie 2004 Poor control on risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 291 335 342 1:CAS:528:DC%2BD2cXmtlentQ%3D%3D 10.1001/jama.291.3.335 14734596 (Pubitemid 38101606)
22. HC Gerstein ME Miller RP Byington, et al. 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 2559 1:CAS:528:DC%2BD1cXnt1Wjs7s%3D 10.1056/NEJMoa0802743 18539917 (Pubitemid 351831356)
23. Skyler JS, Bergenstal R, Bonow RO et al (2009) American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 20;119(2):351-357
24. RR Holman SK Paul MA Bethel DR Matthews HA Neil 2008 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 15 1577 1589 1:CAS:528:DC%2BD1cXht1Wgt7nK 10.1056/NEJMoa0806470 18784090
25. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B (2009) American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32(1):193-203